Biosoft aims to become a conductor between fundamental science and services. It helps business representatives to find appropriate scientific partners.
VISION AND MISSION
Biosoft aims to put on stream fundamental science problems that phramaceutical and other lifesciences companies are forced to deal with in order to get a desired result.
The BioUML platform is certified and intellectual rights on it totally belong to the Biosoft company
Biosoft is totally responsible for the quality of all of the services it provides.
Our top management team unites experts in science and administration, that's why Biosoft is developing quickly and efficiently.
Biosoft has collected a team of real experts to grant you top quality scientific services.
Track the news on our web site as we have almost started the countdown to the very first public release of our workflow system "From genome to target" for automatized search of new therapeutic targets.
Come and join us on the grand opening of Biosoft's new office in Skolkovo Technopark on April 21st! You will find interesting lectures on bioinformatics, workshops and a hakaton on search for personalized biomarkers and drug targets on real patient's data.
Join us on April 13th if you are interested in molecular medicine and drug development, as we are going to give a webinar on the basic approach for searching for new drug targets and biomarkers.
Biosoft has gathred unique experts in the fields of systems biology, bioinformatics, data analysis, molecular biology, chemoinformatics etc. Our team unites scientists from all over the world. Each of its members has a unique competence in a corresponding field and this allows us to guarantee you the best result of what is possible. We introduce you the main scientific specialists of our team:
Dr. Hiroaki Kitano is a scientific advisor of the Biosoft project. He is the director of the Systems Biology Institute (http://www.sbi.jp/) and a director of Sony Computer Science Laboratories, Inc., Japan. He is one of the main founders of systems biology initiative in the World.
Prof. Rudi Balling is a scientific advisor of the Biosoft project. He is a director and founder of LCSB - Luxembourg Centre for Systems Biomedicine. He also is a professor at the University of Luxembourg.
Prof. Dmitri Petrov is a scientific advisor of the Biosoft project. He is a professor of Humanities and Sciences in the Biology Department at Stanford. He received his PhD in 1997 from Harvard University under the guidance of Daniel Hartl and Richard Lewontin.
He is director of the department of bioinformatics at the University
Medical Center Göttingen, concurrent professor at Nanjing University,
founder of BIOBASE GmbH and founder and CEO of geneXplain GmbH.
Prof. Alexander Tropsha is a scientific advisor of the Biosoft project. He is a professor and an associate dean for research at the Eshelman School of Pharmacy, UNC-Chapel Hill, NC, USA.